Key Compliance Terms for Your MoCRA-Ready OEM Contract

Navigating the New Frontier: Why Your OEM Contract Needs a MoCRA Makeover The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) has fundamentally reshaped the landscape for cosmetic products sold in the United States. For brands utilizing Original Equipment Manufacturers (OEMs), this regulatory shift places a new premium on contractual clarity and shared responsibility. A simple manufacturing agreement is no longer sufficient; your contract must be a robust legal framework that explicitly addresses MoCRA’s stringent requirements. At RAY, we believe in proactive compliance, ensuring our partners are not just prepared, but are ahead of the curve. This article will detail the critical compliance terms that must be written into your OEM contract to make it MoCRA-ready. Defining Roles: The Responsible Person and Facility Registration MoCRA introduces the concept of a "Responsible Person" – the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label. This entity is ultimately accountable for the product's safety and regulatory compliance. Your OEM contract must clearly define: Who is the Responsible Person: In most OEM relationships, the brand is the Responsible Person. The contract should explicitly state this to avoid any ambiguity. Facility Registration Obligations: MoCRA mandates that all facilities engaged in manufacturing or processing cosmetic products for the U.S. market must register with the FDA. Your contract must obligate your OEM partner to maintain a current and valid FDA registration and to provide you with proof of this registration upon request. It should also specify the process for re-registration, which is required every two years. Contract Clause Example: "Manufacturer (the OEM) warrants that its production facilities are and will remain registered with the U.S. Food and Drug Administration (FDA) as required by MoCRA for the entire duration of this agreement. Manufacturer will provide Brand Owner (the Responsible Person) with a copy of its current registration and any subsequent renewal confirmations." Product Listing and Documentation: The Paper Trail of Compliance Under MoCRA, the Responsible Person must submit a detailed cosmetic product listing to the FDA for each product. This listing includes a list of ingredients, facility information, and other key details. Your OEM contract needs to create a seamless flow of information: Ingredient Disclosure: The contract must require the OEM to provide a complete and accurate list of all ingredients and their respective percentages, including fragrance and flavor components. This is crucial for both the product listing and for substantiating safety. Safety Substantiation Records: The Responsible Person must maintain records supporting the "adequate substantiation of safety" for each product. Your OEM is a key source of this data. The contract should mandate that the OEM provides all necessary documentation, including raw material specifications, safety data sheets (SDS), and results from any stability, preservative efficacy, or other relevant testing. Access to Records: The contract should grant you, as the Responsible Person, the right to access and audit these records to ensure they meet FDA standards. This is vital for due diligence and in the event of an FDA inspection. Adverse Events and Safety Reporting: A Coordinated Response MoCRA establishes a formal system for recording and reporting adverse events. A serious adverse event must be reported to the FDA within 15 business days. This is a tight deadline that requires flawless coordination between the brand and the OEM. Your contract must establish a clear protocol: Immediate Notification: Require your OEM to notify you within a specified, brief timeframe (e.g., 24-48 hours) of any adverse event report they receive related to your products. Information Sharing: The OEM must be contractually obligated to provide all information necessary for you to evaluate the event and,